Akers Joseph A

Director at Omrix Biopharmaceuticals, Inc. · on record since Nov 6, 2006
Director at TITAN PHARMACEUTICALS INC · on record since Nov 12, 2014

Insider trading activity of Akers Joseph A

Transactions on record: 11; since Nov 6, 2006

Open-market buys: 3; $113K

Open-market sells: 0

Companies traded: 2; last filing Jan 5, 2022

Figures computed from official regulatory filings — .

Companies where Akers Joseph A has traded

TITAN PHARMACEUTICALS INC10 tx · $113K · Jan 5, 2022
Omrix Biopharmaceuticals, Inc.1 tx · Nov 6, 2006

Track record of Akers Joseph A

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Akers Joseph A

Co-insiders of Akers Joseph A

Activist Investing LLCTITAN PHARMACEUTICALS INC
ADAMS-GABBERT & ASSOCIATES, LLCTITAN PHARMACEUTICALS INC
AFTING ERNST GUNTER MDTITAN PHARMACEUTICALS INC
ALLEN RICHARD CTITAN PHARMACEUTICALS INC
Alperovitz AsafOmrix Biopharmaceuticals, Inc.
Apple Tree Consolidated BVBA SPRLTITAN PHARMACEUTICALS INC
Apple Tree Investments S.a.r.lTITAN PHARMACEUTICALS INC
Apple Tree Partners IV, L.P.TITAN PHARMACEUTICALS INC
ASCENT INVESTMENT PARTNERS, LLCTITAN PHARMACEUTICALS INC
ATP III GP, Ltd.TITAN PHARMACEUTICALS INC
BAB BIO VENTURES LLPOmrix Biopharmaceuticals, Inc.
BAB BIO VENTURES NVOmrix Biopharmaceuticals, Inc.
BAUER VICTOR J PHDTITAN PHARMACEUTICALS INC
BAW INVESTMENTS, LLCTITAN PHARMACEUTICALS INC
BB BIOVENTURES L POmrix Biopharmaceuticals, Inc.
Beebe KatherineTITAN PHARMACEUTICALS INC
BEHRENS BRENT WAYNETITAN PHARMACEUTICALS INC
Ben-Tzvi AvrahamTITAN PHARMACEUTICALS INC
BF 161 ELECTRIC, LLCTITAN PHARMACEUTICALS INC
BF WYANDOTTE DEVELOPMENT, LLCTITAN PHARMACEUTICALS INC
BHONSLE SUNILTITAN PHARMACEUTICALS INC
Bicknell Family Finance CoTITAN PHARMACEUTICALS INC
Bicknell Family HOlding Co LLCTITAN PHARMACEUTICALS INC
Bicknell Family Management Company, LLCTITAN PHARMACEUTICALS INC
Bicknell Family Management CO TrustTITAN PHARMACEUTICALS INC
BICKNELL PROPERTIES, LLCTITAN PHARMACEUTICALS INC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
TITAN PHARMACEUTICALS INCListing unverified	Jan 5, 2022	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TITAN PHARMACEUTICALS INCListing unverified	Feb 11, 2021	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TITAN PHARMACEUTICALS INCListing unverified	Sep 25, 2018	AwardD (derivative)	200,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TITAN PHARMACEUTICALS INCListing unverified	Sep 25, 2018	Buy	200,000	0.25 USD	$50K	conv 88ClusterFirst in 12mo	SEC
TITAN PHARMACEUTICALS INCListing unverified	Sep 19, 2017	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TITAN PHARMACEUTICALS INCListing unverified	Feb 21, 2017	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TITAN PHARMACEUTICALS INCListing unverified	Jul 19, 2016	Buy	8,000	4.95 USD	$39.6K	conv 81ClusterFirst in 12mo	SEC
TITAN PHARMACEUTICALS INCListing unverified	Jul 19, 2016	Buy	5,000	4.68 USD	$23.4K	conv 61Cluster	SEC
TITAN PHARMACEUTICALS INCListing unverified	Dec 16, 2015	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TITAN PHARMACEUTICALS INCListing unverified	Mar 18, 2015	AwardD (derivative)	12,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Omrix Biopharmaceuticals, Inc.Listing unverified	Nov 6, 2006	AwardD (derivative)	11,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
TITAN PHARMACEUTICALS INCListing unverified	Jan 5, 2022	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TITAN PHARMACEUTICALS INCListing unverified	Feb 11, 2021	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TITAN PHARMACEUTICALS INCListing unverified	Sep 25, 2018	AwardD (derivative)	200,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TITAN PHARMACEUTICALS INCListing unverified	Sep 25, 2018	Buy	200,000	0.25 USD	$50K	conv 88ClusterFirst in 12mo	SEC
TITAN PHARMACEUTICALS INCListing unverified	Sep 19, 2017	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TITAN PHARMACEUTICALS INCListing unverified	Feb 21, 2017	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TITAN PHARMACEUTICALS INCListing unverified	Jul 19, 2016	Buy	8,000	4.95 USD	$39.6K	conv 81ClusterFirst in 12mo	SEC
TITAN PHARMACEUTICALS INCListing unverified	Jul 19, 2016	Buy	5,000	4.68 USD	$23.4K	conv 61Cluster	SEC
TITAN PHARMACEUTICALS INCListing unverified	Dec 16, 2015	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TITAN PHARMACEUTICALS INCListing unverified	Mar 18, 2015	AwardD (derivative)	12,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Omrix Biopharmaceuticals, Inc.Listing unverified	Nov 6, 2006	AwardD (derivative)	11,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC